Tower Research Capital LLC (TRC) - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$83,381
-59.9%
5,254
-52.3%
0.00%
-57.1%
Q2 2023$207,986
+442423.4%
11,022
-9.7%
0.01%
+600.0%
Q1 2023$47
-80.3%
12,208
-74.6%
0.00%
-90.0%
Q4 2022$238
-100.0%
48,057
-53.5%
0.01%
+25.0%
Q3 2022$495,000
+122.0%
103,455
+108.6%
0.01%
+60.0%
Q2 2022$223,000
+869.6%
49,599
+962.3%
0.01%
Q1 2022$23,000
-87.3%
4,669
-80.9%
0.00%
-100.0%
Q4 2021$181,000
-22.6%
24,404
-40.8%
0.00%
-50.0%
Q3 2021$234,000
+185.4%
41,232
+233.3%
0.01%
+200.0%
Q2 2021$82,000
-54.2%
12,370
-44.0%
0.00%
-33.3%
Q1 2021$179,000
+397.2%
22,079
+296.3%
0.00%
+200.0%
Q4 2020$36,000
-96.1%
5,571
-97.8%
0.00%
-90.0%
Q3 2020$913,000
+260.9%
253,754
+361.8%
0.01%0.0%
Q2 2020$253,000
+25200.0%
54,953
+21620.6%
0.01%
Q4 2019$1,000
-98.8%
253
-99.2%
0.00%
-100.0%
Q3 2019$81,000
+8000.0%
33,378
+8592.2%
0.01%
Q1 2019$1,000
-87.5%
384
-76.1%
0.00%
-100.0%
Q4 2018$8,000
-84.9%
1,610
-71.4%
0.00%
-75.0%
Q3 2018$53,000
-25.4%
5,635
-16.9%
0.00%
-33.3%
Q1 2018$71,000
+3450.0%
6,779
+2167.2%
0.01%
Q4 2017$2,000
-50.0%
299
-47.4%
0.00%
Q3 2017$4,000
-80.0%
568
-94.1%
0.00%
-100.0%
Q4 2016$20,000
+1900.0%
9,632
+8736.7%
0.00%
Q4 2015$1,000
-99.4%
109
-99.4%
0.00%
-100.0%
Q3 2015$164,000
-29.3%
17,112
+6.0%
0.02%
-23.8%
Q2 2015$232,000
-30.1%
16,148
-56.5%
0.02%
-48.8%
Q1 2015$332,000
+191.2%
37,123
+98.8%
0.04%
+272.7%
Q4 2014$114,000
+2750.0%
18,669
+4532.5%
0.01%
Q3 2014$4,000
-93.1%
403
-88.1%
0.00%
-100.0%
Q3 2013$58,000
+383.3%
3,387
+352.8%
0.01%
+500.0%
Q2 2013$12,0007480.00%
Other shareholders
IMMUNOGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders